Brivaracetam

Product NDC
0121-1074
11-digit product format
001211074
Labeler code
0121
Product ID
0121-1074_6e474aba-29da-4afb-801c-000ca4393f74
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Brivaracetam
Dosage form
SOLUTION
Route
ORAL
Labeler
PAI Holdings, LLC dba PAI Pharma
Application
ANDA218494
Marketing category
ANDA
Marketing start
2026-02-23
Substance
BRIVARACETAM
Active strength
10 mg/mL
Pharmacologic classes
Epoxide Hydrolase Inhibitors [MoA]
DEA schedule
CV
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218494-001BRIVARACETAMBRIVARACETAM10MG/MLSOLUTION / ORALAA2026-02-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A218494-001AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218494-001BRIVARACETAM10MG/MLSOLUTION / ORALAA2026-02-23a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218494-001AA1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Brivaracetam
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
BRIVARACETAM10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
U863JGG2IAInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1739785Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
57627ea9-3b14-4428-ad95-6ea25ecaef31Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1447c696-6954-40c0-b275-6f6c780ca8b7Product name120160323
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0121-1074-10Brivaracetam300 mL in 1 BOTTLESOLUTION3003
0121-1074-10Brivaracetam1 in 1 CARTONSOLUTION13

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0121-1074-10ML - Milliliter0121-10747ac4b533-fe28-466c-9a34-aa7fda2152c212026-03-17

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
brivaracetamBRIVARACETAMZhejiang Poly Pharm. Co., Ltd.aef3ee92-e2a6-4135-94b2-b893f893d5f22026-02-23Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218494
application number: ANDA218494
BrivaracetamBRIVARACETAMPAI Holdings, LLC dba PAI Pharma57627ea9-3b14-4428-ad95-6ea25ecaef312026-02-03Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218494
application number: ANDA218494
ndc (product): 0121-1074

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1739785brivaracetam 10 MG in 1 mL Oral SolutionPSN57627ea9-3b14-4428-ad95-6ea25ecaef313
1739785brivaracetam 10 MG/ML Oral SolutionSCD57627ea9-3b14-4428-ad95-6ea25ecaef313
1739785brivaracetam 10 MG per 1 ML Oral SolutionSY57627ea9-3b14-4428-ad95-6ea25ecaef313

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0121-1074-10001211074101 BOTTLE in 1 CARTON (0121-1074-10) / 300 mL in 1 BOTTLE1 bottle2026-02-23NoNoCurrent